| Literature DB >> 25019646 |
Changming Huang1, Mi Lin1, Qiyue Chen1, Jianxian Lin1, Chaohui Zheng1, Ping Li1, Jianwei Xie1, Jiabin Wang1, Jun Lu1.
Abstract
BACKGROUND: The present study introduced a modified delta-shaped gastroduodenostomy (DSG) technique and assessed the safety, feasibility and clinical results of this procedure in patients undergoing totally laparoscopic distal gastrectomy (TLDG) for gastric cancer (GC).Entities:
Mesh:
Year: 2014 PMID: 25019646 PMCID: PMC4096929 DOI: 10.1371/journal.pone.0102736
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Trocar placements for totally laparoscopic distal gastrectomy.
Figure 2The procedures of modified delta-shaped gastroduodenostomy before closing the common stab incision.
a Diagram showing that the stapler was positioned across the duodenum vertical to the long axis in the predetermined position and fired to transect the duodenum by rotating 90 degrees from back to front. b Intraoperative image showing that the stapler was positioned across the duodenum vertical to the long axis in the predetermined position and fired to transect the duodenum by rotating 90 degrees from back to front. c Diagram showing that the stomach was resected by successively transecting from the greater curvature to the lesser curvature with two staplers. d Intraoperative image showing that the stomach was resected by successively transecting from the greater curvature to the lesser curvature with two staplers. e Diagram showing that the stapler was positioned to join the posterior walls together. f Intraoperative image showing that the stapler was positioned to join the posterior walls together. g Diagram showing the V-shaped anastomosis on the posterior wall. h Intraoperative image showing the V-shaped anastomosis on the posterior wall.
Figure 3The differences between the conventional delta-shaped gastroduodenostomy (DSG) and the modified DSG.
a Diagram showing that three sutures were added to each end of the common stab incision and the cutting edges of the stomach and duodenum to obtain an involution and pull in the conventional DSG. b Diagram showing the completed involution of the common stab incision using the instruments of the surgeon and assistant with the blind angle of the duodenum being pulled up into the stapler in the modified DSG. c Diagram showing the completed conventional DSG with two intersections of the gastroduodenal cutting edge and the common closed edge. d Diagram showing the completed modified DSG with only one intersection of the gastric cutting edge and the common closed edge. e Intraoperative image showing the completed involution of the common stab incision using the instruments of the surgeon and assistant with the blind angle of the duodenum being pulled up into the stapler in the modified DSG. f Intraoperative image showing the completed inverted T-shaped appearance of anastomosis in the modified DSG.
Figure 4The film of upper gastrointestinal radiography.
The film of upper gastrointestinal radiography with diatrizoate meglumine as the contrast medium on postoperative day 7 for one patient underwent the modified delta-shaped gastroduodenostomy. The inner diameter of the anastomosis was measured the length of the white arrow as shown in the figure.
Figure 5The gastroscope image of one patient underwent the modified delta-shaped gastroduodenostomy on postoperative 3 months.
Clinicopathological Characteristics of patients undergoing TLDG with modified DSG for GC (n (%)).
| Demographics | n = 102 | Oncologic outcomes | n = 102 |
| Age(years) | 60.0±12.0 | Tumor size(mm) | 35.5±20.2 |
| Gender | AJCC pT stage | ||
| Male | 74(72.6) | T1 | 46(45.1) |
| Female | 28(27.5) | T2 | 28(27.5) |
| BMI(kg/m2) | 22.2±3.2 | T3 | 24(23.5) |
| Hemoglobin(g/L) | 126.5±22.4 | T4a | 4(3.9) |
| Albumin(g/L) | 41.0±4.6 | AJCC pN stage | |
| White blood cell count(10∧9/L) | 6.1±1.9 | N0 | 59(57.8) |
| Preoperative nutritional support | 34(33.3) | N1 | 24(23.5) |
| Preoperative BPT | 5(4.9) | N2 | 15(14.7) |
| With hemorrhage | 11(10.8) | N3 | 4(3.9) |
| With pyloric obstruction | 1(1.0) | AJCC pTNM stage | |
| History of abdominal operation | 18(17.7) | IA | 39(38.2) |
| Comorbidity disease | 39(38.2) | IB | 21(20.6) |
| Cardiovascular | 31(30.4) | IIA | 15(14.7) |
| Diabetes | 12(11.8) | IIB | 11(10.8) |
| Pulmonary | 3(2.9) | IIIA | 9(8.8) |
| Gout | 2(2.0) | IIIB | 7(6.9) |
| Hypothyroidism | 1(1.0) | Pathology | |
| Hyperthyroidism | 1(1.0) | Differentiation | 82(80.4) |
| – | – | Undifferentiation | 20(19.6) |
TLDG, totally laparoscopic distal gastrectomy; DSG, delta-shaped gastroduodenostomy; GC gastric cancer; BMI, body mass index; BPT, blood products transfusion; AJCC, American Joint Committee on Cancer 7th; pTNM, pathological tumor node metastasis.
Surgical outcomes of patients undergoing TLDG with modified DSG for GC.
| Items | n = 102(%) |
| Conversion to open surgery | 0 (0.00) |
| Extent of LN dissection(n, D1+/D2) | 9/93 |
| Number of dissected LNs (per case) | 35.1±11.1 |
| Operation time(min) | 150.6±30.2 |
| Anastomosis time(min) | 12.2±4.2 |
| Intraoperative blood loss(ml) | 48.2±33.2 |
| Time to first flatus (days) | 3.8±1.3 |
| Resume liquid diet time (days) | 5.0±1.0 |
| Resume soft diet time (days) | 7.4±2.1 |
| Postoperative hospital stay (days) | 12.0±6.5 |
| Anastomosis size (mm) | 30.4±3.6 |
LN, lymph node. DSG, delta-shaped gastroduodenostomy. TLDG, totally laparoscopic distal gastrectomy. GC gastric cancer.
Postoperative complications of patients undergoing TLDG with modified DSG for GC.
| Items | n = 102 |
|
| |
| Anastomotic leakage | 2 |
| Anastomotic stricture | 0 |
| Anastomotic hemorrhage | 0 |
|
| |
| Postoperative celiac infection | 1 |
| Respiratory infection | 3 |
| Inflammatory intestinal obstruction | 1 |
| Lower incomplete gastrointestinal obstruction | 1 |
| Gastric atony | 2 |
| Overall postoperative complications | 8(7.84%) |
| Postoperative mortality [n (%)] | 0(0%) |
TLDG totally laparoscopic distal gastrectomy; DSG delta-shaped gastroduodenostomy; GC gastric cancer.
* Repeated cases were not included.
Risk factors influencing complications after TLDG with modified DSG for GC.
| Items | With complications (n = 8) | Without complications (n = 94) | Univariate analysis p | Multivariate analysis | |
| 95% CI | p | ||||
| Gender | 0.162 | ||||
| Male | 8(100%) | 66(70.2%) | |||
| Female | 0(0%) | 28(29.8%) | |||
| Age(years) | 69.1±9.9 | 59.2±11.9 | 0.024 | 0.953–1.138 | 0.368 |
| BMI | 28.80±2.99 | 22.29±3.19 | 0.234 | ||
| Hemoglobin (g/L) | 128.13±17.89 | 126.56±23.21 | 0.853 | ||
| White blood cell coun (10∧9/L) | 7.24±2.87 | 6.04±1.86 | 0.099 | ||
| Albumin (g/L) | 41.01±3.24 | 40.89±4.72 | 0.941 | ||
| With hemorrhage | 0.002 | 0.027–0.939 | 0.042 | ||
| Yes | 4(50%) | 7(7.4%) | |||
| No | 4(50%) | 87(92.6%) | |||
| Preoperative NS | 0.896 | ||||
| Yes | 2(25%) | 32(34%) | |||
| No | 6(75%) | 62(66%) | |||
| Preoperative BPT | 0.854 | ||||
| Yes | 1(12.5%) | 4(4.3%) | |||
| No | 7(87.5%) | 90(95.7%) | |||
| History of abdominal operation | 0.378 | ||||
| Yes | 0(0%) | 18(19.1%) | |||
| No | 8(100%) | 76(80.9%) | |||
| Comorbidity disease | 0.064 | ||||
| Yes | 6(75%) | 33(35.1%) | |||
| No | 2(25%) | 61(64.9%) | |||
| Cardiovascular | 0.014 | 0.041–2.847 | 0.322 | ||
| Yes | 6(75%) | 25(26.6%) | |||
| No | 2(25%) | 69(73.4) | |||
| Diabetes | 1.000 | ||||
| Yes | 1(12.5%) | 11(11.7%) | |||
| No | 7(87.5%) | 83(88.3%) | |||
| Pulmonary | 0.564 | ||||
| Yes | 1(12.5%) | 2(2.1%) | |||
| No | 7(87.5%) | 92(97.9%) | |||
| Operative time (min) | 139.4±22.4 | 151.5±30.7 | 0.278 | ||
| Anastomosis time(min) | 11.9±4.5 | 12.2±4.2 | 0.822 | ||
| Number of dissected LNs (per case) | 35.9±9.3 | 35.0±11.3 | 0.835 | ||
| Intraoperative blood loss (mL) | 45.0±31.2 | 48.6±33.0 | 0.769 | ||
| Tumor size(mm) | 40.0±22.0 | 35.1±20.1 | 0.516 | ||
| Pathology | 0.993 | ||||
| Differentiated | 6(75%) | 77(81.9%) | |||
| Undifferentiated | 2(25%) | 17(18.1%) | |||
| pT | 0.445 | ||||
| T1 | 2(25%) | 43(45.1%) | |||
| T2–T4a | 6(75%) | 51(54.3%) | |||
| pN | 1.000 | ||||
| N0 | 5(62.5%) | 53(56.4%) | |||
| N1–N3 | 3(37.5%) | 41(43.6%) | |||
| pTNM | 0.924 | ||||
| I | 4(50%) | 55(58.5%) | |||
| II–III | 4(50%) | 39(41.5%) | |||
TLDG totally laparoscopic distal gastrectomy; DSG delta-shaped gastroduodenostomy; GC gastric cancer; CI, confidence interval; NS, nutritional support; BPT, blood products transfusion; LN, lymph node.